Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance Deanna D. Hill; Jennifer R. Kramer; Kassie R. Chaffin; T. Christopher Mast; Michael N. Robertson; Fasiha Kanwal; Barbara A. Haber;

Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver Cristiane A. Villela-Nogueira; Maria Lúcia Gomes Ferraz; Mário Guimarães Pessoa; Francisco José Dutra Souto; Letícia Cancella Nabuco; Henrique Sérgio Moraes Coelho; Ezequiel Ridruejo; Marcelo Silva; Paulo Lisboa Bittencourt; Carlos Eduardo Brandão-Mello;

A multinational survey of physician knowledge about management of chronic hepatitis C Mohamed El-Kassas; Yusuf Yilmaz; Chun-Jen Liu; Marlen I. Castellanos Fernández; Yuichiro Eguchi; Khalid Al-Naamani; Doaa Abdeltawab; Mohammed A. Medhat; Wah-Kheong Chan; Stuart Gordon; Vasily Isakov; Ming Lung Yu; Maria Buti; George V. Papatheodoridis; Fatema Nader; Andrei Racila; Linda Henry; Maria Stepanova; Zobair M. Younossi;